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Abstract
Background: In a clinical trial, internet-based cognitive behavioral therapy (I-CBT) embedded in stepped care was established
as noninferior to face-to-face cognitive behavioral therapy (CBT) for chronic fatigue syndrome (CFS). However, treatment effects
observed in clinical trials may not necessarily be retained after implementation.
Objective: This study aimed to investigate whether stepped care for CFS starting with I-CBT, followed by face-to-face CBT,
if needed, was also effective in routine clinical care. Another objective was to explore the role of therapists’ attitudes toward
electronic health (eHealth) and manualized treatment on treatment outcome.
Methods: I-CBT was implemented in five mental health care centers (MHCs) with nine treatment sites throughout the Netherlands.
All patients with CFS were offered I-CBT, followed by face-to-face CBT if still severely fatigued or disabled after I-CBT.
Outcomes were the Checklist Individual Strength, physical and social functioning (Short-Form 36), and limitations in daily
functioning according to the Work and Social Adjustment Scale. The change scores (pre to post stepped care) were compared
with a benchmark: stepped care from a randomized controlled trial (RCT) testing this treatment format. We calculated correlations
of therapists’ attitudes toward manualized treatment and eHealth with reduction of fatigue severity.
Results: Overall, 100 CFS patients were referred to the centers. Of them, 79 started with I-CBT, 20 commenced directly with
face-to-face CBT, and one did not start at all. After I-CBT, 48 patients met step-up criteria; of them, 11 stepped up to face-to-face
CBT. Increase in physical functioning (score of 13.4), social functioning (20.4), and reduction of limitations (10.3) after stepped
care delivered in routine clinical care fell within the benchmarks of the RCT (95% CIs: 12.8-17.6; 25.2-7.8; and 7.4-9.8,
respectively). Reduction of fatigue severity in the MHCs was smaller (12.6) than in the RCT (95% CI 13.2-16.5). After I-CBT
only, reduction of fatigue severity (13.2) fell within the benchmark of I-CBT alone (95% CI 11.1-14.2). Twenty therapists treated
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between one and 18 patients. Therapists were divided into two groups: one with the largest median reduction of fatigue and one
with the smallest. Patients treated by the first group had a significantly larger reduction of fatigue severity (15.7 vs 9.0; t=2.42;
P=.02). There were no (statistically significant) correlations between therapists’ attitudes and reduction in fatigue.
Conclusions: This study is one of the first to evaluate stepped care with I-CBT as a first step in routine clinical care. Although
fatigue severity and disabilities were reduced, reduction of fatigue severity appeared smaller than in the clinical trial. Further
development of the treatment should aim at avoiding dropout and encouraging stepping up after I-CBT with limited results.
Median reduction of fatigue severity varied largely between therapists. Further research will help understand the role of therapists’
attitudes in treatment outcome.
(J Med Internet Res 2019;21(10):e14037)  doi: 10.2196/14037
KEYWORDS
eHealth; cognitive behavioral therapy; health plan implementation; chronic fatigue syndrome; attitudes
Introduction
Chronic fatigue syndrome (CFS) is characterized by severe,
persistent, and disabling fatigue. The fatigue is neither explained
by the presence of a medical or psychiatric condition nor
alleviated by rest. According to the revised Centers for Disease
Control and Prevention (CDC) consensus criteria for CFS from
2003, 4 out of the following 8 additional symptoms should be
present: problems with concentration and memory, sore throat,
tender lymph nodes, headache, muscle pain, multi-joint pain,
unrefreshing sleep, and postexertional malaise [1,2].
Cognitive behavioral therapy (CBT) for CFS is aimed at
changing behavior and beliefs that maintain symptoms and can
effectively reduce fatigue and disability [3,4]. Face-to-face CBT
is intensive, requiring 12 to 16 sessions, and therapists need
additional training to effectively deliver CBT for CFS [5,6].
Unfortunately, few therapists are trained for CBT for CFS, and
therefore, treatment capacity is limited. To overcome this
problem, Internet-based CBT (I-CBT) for CFS was developed,
which was expected to demand less of therapist resources (ie,
therapist time) and also be less burdensome for patients (no
need to travel and working at own pace [7]). I-CBT for adult
CFS patients was compared with a waiting-list condition in a
randomized controlled trial (RCT) in a tertiary CFS treatment
center in the Netherlands. It was found to lead to a significant
reduction of fatigue and disability while taking approximately
45% less therapist time compared with that of face-to-face CBT
(5:23/12:00 hours) [8]. As outcomes appeared less favorable
than in face-to-face CBT and not all patients profited, I-CBT
was subsequently embedded in stepped care: patients who were
still severely fatigued or disabled after I-CBT could step up to
face-to-face CBT. Stepped care was compared with care as
usual, that was, only face-to-face CBT in a randomized
controlled noninferiority trial. Stepped care was effective, and
more efficient than care as usual, as it required less therapist
time [9].
However, care that has proven to be effective within the context
of an RCT, in a tertiary research center, is not necessarily
equally effective in routine clinical care [10,11]. In case of CFS,
it was found that face-to-face CBT could be provided in mental
health care centers (MHCs) with the same magnitude of
treatment effect as found in RCTs conducted in tertiary CFS
research centers, although not all MHCs reached the benchmark
[5,6]. It is not yet known if I-CBT for CFS implemented in
routine care is effective. For I-CBT in other disorders, such as
depression and anxiety, tinnitus, and irritable bowel syndrome,
the first results suggest that it can be successfully implemented
in routine clinical care, but more studies are needed [12]. Despite
the evidence of the efficacy of electronic health (eHealth), it is
incorporated in routine clinical care on a far smaller scale than
expected [13,14]. Therefore, it is not yet known how I-CBT can
best be embedded in routine clinical care. The first aim of this
study is to investigate whether stepped care, comprising I-CBT
followed by face-to-face CBT, can be delivered in routine
clinical care as effective as in the RCT [9], with respect to
treatment outcome.
Second, we are interested in the role of therapist variations on
treatment outcomes in routine clinical care. The extent to which
differences between the effectiveness of individual therapists
explain variance in treatment outcome differs largely over
studies. Less influence of therapist variation was associated
with therapists being more experienced and the use of treatment
manuals [15]. With respect to the treatment of CFS, in a large
study in a specialist center, variance in outcome could not be
explained by therapist factors. A possible explanation for this
finding was that in specialized centers, therapists received the
same training and supervision and had the same therapeutic
orientation [16]. In a study evaluating the role of the therapist
in routine clinical care for CFS (ie, face-to-face CBT), 21% of
the variance in treatment outcome was explained by the therapist
effect. Attitudes of individual therapists (ie, the attitude toward
the use of treatment manuals) were associated with treatment
outcome [17].
If therapists’ attitudes influence outcome, this provides an
opportunity to enhance the efficacy of the treatment, as attitudes
can be altered, for example, by experience or training [18,19].
We aimed to investigate if therapists’ attitudes toward treatment
manuals also influenced outcome in implementation of I-CBT
and stepped care for CFS in clinical routine care. Furthermore,
we were interested in the role of attitudes of therapists toward
eHealth. It was recently found that a positive attitude of the
therapists toward eHealth was associated with sharing of more
assignments with the therapist by the patient [20]. It was
expected that attitudes of therapists influenced treatment
outcome in our implementation study.
To answer our research questions, stepped care was implemented
in 5 MHCs, with outpatient treatment centers in 9 different cities
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spread over the Netherlands. All CFS patients who were referred
for CBT were offered I-CBT. If still severely fatigued or
disabled after I-CBT, they were offered additional face-to-face
CBT. We compared the reduction of fatigue and disability with
the benchmark, which was, the effect of stepped care with I-CBT
found in an RCT in a tertiary treatment center [9]. Both the
effects of the I-CBT (the first step) and the full stepped care
model were evaluated. We also explored outcome variations
between individual therapists. More specifically, we determined
if variation in treatment outcome of stepped care could be
explained by therapists’ attitudes toward manualized treatment
of CFS and the use of eHealth.
Methods
Design
This was an observational study with a pre- and posttreatment
study design. Reduction of fatigue severity and level of
disabilities were compared with a statistical benchmark, derived
from a randomized controlled noninferiority trial for stepped
care with I-CBT in a tertiary treatment facility [9] (registered
in the Netherlands Trial Register as NTR4809). The latter study
included 2 stepped care conditions, of which, the format of
therapist feedback during I-CBT differed. In 1 condition,
therapists' feedback was given at predefined time points. In the
other condition, therapists' feedback was on demand. Both
conditions were combined to represent the benchmark in this
study (n=242).
MHCs that already offered face-to-face CBT for CFS for at
least 1 year were asked to participate in the study. In the
participating MHCs, I-CBT was implemented as a first step of
stepped care, with additional face-to-face CBT as the second
step.
The medical ethical committee of the Radboud university
medical center ruled that the study did not fall under the scope
of the Medical Research Involving Human Subjects Act (see
Multimedia Appendix 1).
Participants
Participating Mental Health Care Centers
Table 1 shows the characteristics of the participating MHCs.
The participating therapists were previously trained to deliver
face-to-face CBT, during a 4-day training program in CBT for
CFS followed by 2-week supervision for 1 year. All had gained
experience in the face-to-face treatment of CFS [5].
In the context of the implementation of I-CBT, therapists had
2 additional training days. The first day focused on delivering
I-CBT. The second day was scheduled after the first patients
received treatment. The second training day focused on
overcoming challenges that were met during delivering I-CBT
and the process of stepping up to face-to-face CBT when
necessary. Specific for face-to-face CBT after I-CBT is that
although it follows a treatment manual [21], the starting point
differs for each patient. To tailor the CBT to the patients’
process, therapists were trained to (1) identify what was already
achieved during I-CBT and what was needed to further improve
and (2) motivate patients to actually step up to face-to-face
CBT. Therapists were trained to recognize and modify reduced
expectations of the patient toward face-to-face CBT, after
limited results during I-CBT.
Table 1. Characteristics of the participating mental health care centers.
TherapistsLocation site(s) in the NetherlandsTreatment sites, nMental health care center
2-3 psychologists per siteCentral and west (the 4 largest cities of the
Netherlands)
4PsyQ Parnassia Groep
2 psychologists per siteNortheast2PsyQ Lentis
2 psychologistsSouth1PsyQ MET ggz
3 psychologistsEast1GGNet
I-CBTa: 4 psychiatric nurses; face-to-face
CBTb: 3 psychologists
Central southwest1GGz Westelijk Noord-Brabant
aI-CBT: internet-based cognitive behavioral therapy.
bCBT: cognitive behavioral therapy.
Participating Patients
All adult patients referred for the treatment of CFS could
participate if the following criteria were met: (1) a physician
had concluded that the patient suffered from severe and disabling
fatigue not explained by a known somatic or psychiatric
condition; (2) the 2003 CDC consensus criteria for CFS were
met (ie, severe, disabling fatigue was present, lasting for at least
6 months, accompanied by at least 4 out of 8 additional
symptoms) or patients met criteria for idiopathic chronic fatigue
(ICF) syndrome (ie, reported severe and persistent fatigue but
did not meet all CDC criteria, <4 additional symptoms, or less
impact on daily functioning [22]). Inclusion criteria for both
patient groups were the presence of severe and persistent fatigue,
as indicated by a score of ≥35 on the Checklist Individual
Strength (CIS) Fatigue Severity Subscale [23], limitations in
functioning according to the Short Form-36 (SF-36) Physical
or Social Scale <65 [24], or both >65 but the patient was limited
in daily functioning according to a clinical interview, for
example, worked less; and (3) the patient had computer and
internet access. There were no specific exclusion criteria.
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Intervention
All patients were offered I-CBT as a first step of treatment. If
patients met step-up criteria after 6 months of I-CBT (still
severely fatigued as indicated by CIS fatigue severity ≥35 or
limited in functioning as indicated by SF-36 Physical or Social
Functioning Scale ≤65), face-to-face CBT was offered.
Both forms of CBT were based on a treatment manual [21] that
has been used in RCTs testing the efficacy of I-CBT and
face-to-face CBT for CFS [25,26]. CBT comprises interventions
aimed at changing behavior and cognitions that maintain CFS
symptoms. It starts with setting concrete goals in terms of
activity, which when reached, imply recovery (ie, no longer
severely fatigued and disabled). Patients learn to establish a
fixed sleep-wake cycle to recognize and modify dysfunctional
cognitions and redirect their focus on symptoms to other matters.
After this, patients start with a graded (physical) activity
program, usually walking or cycling. The activity program is
tailored to the patient, based on their activity pattern. The
increase in activity is time contingent, irrespective of symptoms.
In the same manner, social and mental (eg, reading) activities
are increased and personal goals are attained.
The efficacy of I-CBT was tested in an RCT [8], and it is
described in detail elsewhere [27]. The intervention comprises
7 modules corresponding to the different elements of the
face-to-face protocol. After the first module is finished (getting
started and goal setting), the following 5 modules become
accessible. These modules were as follows: regulate sleep-wake
cycle, helpful beliefs about fatigue, how to communicate with
others about CFS, and gradually increasing my activity. When
the sixth module reaching my goals step by step is finished, the
seventh module opens (evaluation and the future). The duration
of the modules differed, and the patient could work through
them at his or her own pace for 6 months. Therapists were
instructed to provide feedback weekly in the first month and at
least fortnightly in the following 5 months. Patients were sent
reminders if they did not report on their progress according to
the aforementioned schedule. Therapists could respond to an
assignment the patient completed or send an email via the
platform. Feedback was aimed at helping the patients change
their behavior and cognitions according to the principles they
learned in the modules [27].
Accessibility differed between MHCs. A total of 3 MHCs used
the same platform as the tertiary treatment center, and 2 MHCs
incorporated the content of the intervention into their own
eHealth portal. All used the same treatment content.
After 6 months of I-CBT, patients were invited for an
face-to-face evaluation session and offered additional
face-to-face CBT when they still met the aforementioned step-up
criteria. The face-to-face CBT was delivered according to the
treatment manual, although the starting point was tailored to
the needs of the patient, as some cognitions and behaviors
already changed during I-CBT. During the evaluation session,
it was examined which cognitions and behavior remained
dysfunctional and would be the focus of the additional
face-to-face CBT. The number of CBT sessions could vary, and
the expected maximum duration was 6 months. The face-to-face
CBT therapist was preferably the same therapist who delivered
I-CBT. In 1 MHC, this was not possible, as I-CBT was provided
by a psychiatric nurse, whereas the face-to-face CBT was
provided by a psychologist. Information on the course of the
treatment was given to the psychologist.
Measures
Before the start of the study, all therapists were asked to
complete questionnaires assessing their attitudes toward the
manualized treatment and the use of eHealth.
Patient data were collected by therapists. Some MHCs used
digital questionnaires, some used pencil and paper versions of
the outcome measures. The therapists gave each participant a
unique research number and entered the relevant data into a
spreadsheet, listed by research number and without personal
information, except for age and sex. The spreadsheet was
accessible to the researcher.
For patients who received the full stepped care, outcomes were
measured at baseline, after I-CBT (6 months after start), and
directly after face-to-face CBT (posttreatment assessment). For
patients who received I-CBT only, the outcome directly after
I-CBT was used as posttreatment assessment.
Fatigue Severity
Fatigue severity was measured with a fatigue questionnaire, the
20-item CIS [28], that measured different aspects of fatigue.
The Fatigue Severity subscale is used to assess the level of
fatigue and comprises 8 items, scored on a 7-point Likert scale
(range 8-56, higher scores indicate more severe fatigue). The
CIS has proven to be reliable (Cronbach alpha for fatigue
severity subscale ranges between .69 and .94 [23,28]) and valid
and has been used extensively in CFS research as outcome
measure [28].
Functioning
Physical and social functioning was measured with the Medical
Outcomes Survey SF-36 [24], a reliable and valid instrument
to measure health status [29]. Cronbach alpha of the Dutch
version is .92 for the Physical Functioning Subscale and .71 for
the Social Functioning Subscale [30]. The Physical Functioning
Subscale assesses physical functioning with 10 items. Scores
on the scale range from 0 to 100, with higher scores indicating
better physical functioning. The Social Functioning Subscale
assesses impairment in social functioning with 2 questions
scored. Total scores range from 0 to 100; higher scores indicate
better social functioning.
Impairment in daily functioning was measured with the Work
and Social Adjustment Scale (WSAS [31]). This scale assesses
functioning at work, in home management, and in social and
leisure activities, using 5 items, on a scale ranging from 0 to 8
(range of total score is 0-40, with higher scores indicating more
impairment). The Dutch version of the WSAS is validated in
CFS patients; Cronbach alpha is .89 [32].
Additional Symptoms
The number of additional CDC symptoms [1] was registered
during the interview. Some therapists used a pen-and-paper
checklist that systematically checked existing symptoms and a
minimal duration of 6 months. The symptom maximum was 9,
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as concentration and memory problems were recorded
separately.
Therapists’ Attitudes
Therapists’ attitudes toward the use of treatment manuals were
assessed with a questionnaire developed by Addis et al [33] to
measure attitudes of psychologists. It measures 2 constructs:
(1) Positive Outcome (7 items), which reflects the attitude that
manuals can contribute positively to treatment outcome
(Cronbach alpha=.93) and (2) Negative Process (10 items),
which reflects the attitude that the use of treatment manuals
negatively influence the treatment process (Cronbach
alpha=.80). A Dutch version was used, with a 6-point scale
scored from 0 to 5 (positive outcome range 0-35, negative
process range 0-50) [17].
Attitudes toward the use of eHealth were measured with an
18-item version of the eHealth attitude list [19]. The scale
Possibilities of eHealth contains 7 items (5-point Likert scale,
range 7-35), and higher scores reflect the attitude that eHealth
can be valuable. The scale eHealth Negative Effects contains 9
items (5-point Likert scale, range 9-45), and higher scores
represent the attitude that eHealth poses a threat to the therapy
process. The scale Computer Competence contains 2 items
(5-point Likert scale, range 2-10), and a higher score indicates
that the therapist feels competent in using computers. Structural
and internal validity and internal consistency are good
(Cronbach alpha between .83 and .89) [19,20].
Statistical Analyses
Analyses were conducted after imputation of missing primary
outcomes after I-CBT and missing primary and secondary
outcomes at posttreatment (after face-to-face CBT or after
I-CBT for patients who did not receive face-to-face CBT), using
multiple imputations and assuming data were missing at random.
A total of 20 imputations were performed. CIS, SF-36 Physical
functioning and Social functioning, and total score on the WSAS
at baseline and posttreatment were entered as predictors and
variables to impute.
In the dataset used for the statistical benchmark [9], the CIS
and the SF-36 Physical functioning were imputed in the same
manner. For the purpose of this study, WSAS and SF-36 Social
functioning scale were imputed likewise in the dataset.
Imputation and statistical analyses were performed with IBM
SPSS version 22.
Treatment Effects
Treatment effects were tested with paired samples t tests for
each outcome measure. To answer the primary research
question, it was determined whether the change score between
baseline and posttreatment assessment fell within the 95% CI
of the change scores found in the RCT performed in the tertiary
CFS research center (n=242) [9].
To specifically explore the efficacy of I-CBT implemented in
the MHCs, fatigue severity before and after I-CBT was
compared using a paired samples t test, and the change score
in fatigue severity of I-CBT was compared with the benchmark
of I-CBT from the RCT.
Uncontrolled effect sizes (within group Cohen d) were
calculated for the CIS fatigue severity subscale, SF-36 physical
and social functioning, and for the WSAS total score [34]. This
was done by dividing the difference between the mean at
baseline and postassessment by a pooled standard deviation
(√[SDpre2+SDpost2]/2). CIs were calculated following Hunter
and Schmidt [35].
A sensitivity analysis was performed, in which missing data on
CIS fatigue severity were not imputed but replaced by the
maximum score (56). This was done with the assumption that
patients who had no postassessment deteriorated. In the
benchmark study, there were no missing CIS values.
Proportion of Patients With Clinically Significant
Improvement in Fatigue Severity
A clinically significant improvement in fatigue severity was
defined as a statistically Reliable Change Index (RCI) of >1.96
SD in CIS fatigue severity [36], in combination with a CIS
fatigue severity score of <35 on postassessment. The score of
<35 indicates that the patient is no longer severely fatigued [28].
The reliability of the CIS used in the RCI calculation was 0.88
[9,23]. An RCI of >1.96 SD means it can be assumed with a
confidence of 95% that the improvement in CIS fatigue severity
is not caused by unreliability of the measure but represents a
true change.
Subgroup Analyses
To facilitate comparison with the benchmark study, in which
patients with ICF syndrome were not included, change scores
were calculated for the subgroup of patients in implemented
stepped care who did meet the CDC criteria for CFS.
Therapists' Attitudes and Treatment Outcome
A mixed-models approach was planned to investigate to what
extent variance in treatment effect could be explained by the
therapists and their attitudes toward I-CBT and the use of
treatment manuals. If the number of patients per therapist would
be too low, variations in treatment outcome between therapists
would be explored by dividing the therapists in 2 groups using
a median split based on CIS fatigue change scores. Reduction
in fatigue severity in patients of both groups would be compared
using a t test.
To explore if therapists’ attitudes toward I-CBT and treatment
manuals were related to treatment outcome, correlations were
calculated between the therapists’ attitude subscale scores and
the mean change score in fatigue severity of their patients. When
no more than 1 item on an attitude subscale was missing, the
missing value was replaced with the mean score on that subscale.
Results
Overview
Data of all 100 participants were analyzed. Postassessment data
of the primary outcome measure (CIS fatigue severity) of 87
participants (87/100, 87.0%) was present.
From October 2014 to December 2016, 125 patients were
referred for treatment for CFS (Figure 1). Of them, 100 were
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eligible to enter the study and were included, 20 had no CFS
(were not severely fatigued or had another diagnosis that
explained the presence of fatigue), and 5 did not want treatment.
Out of the 100 eligible patients, 73 met all CDC criteria for
CFS, 10 patients had <4 additional symptoms, for 14 patients
the number of additional symptoms was unknown, and 3 patients
were not severely impaired in functioning according to the
SF-36 (both social and physical functioning ≥65) but reported
severe impairment during the clinical interview.
In total, 79 patients started with I-CBT as intended, whereas 20
patients started directly with face-to-face CBT (20%). For 7
patients, it was reported that the patient preferred face-to-face
CBT; for the others, reasons were not reported. In the benchmark
study, 14 patients (14/242, 5.8%) who intended to start with
I-CBT, started directly with face-to-face CBT [9], whereas 119
patients (119/766, 15.5%) eligible to enter the trial refused
because they preferred face-to-face CBT. In the implementation
study, 1 patient did not start treatment. For 24 patients (24/79,
30%), the therapist assumed dropout during I-CBT (no response
and no new log-ins observed, or the patient explicitly reported
to have stopped).
After I-CBT, 15 patients (15/79, 19%) did not meet the step-up
criteria (were no longer severely fatigued or disabled). For 16
patients (16/79, 20%), it is not known whether step-up criteria
were met, as post–I-CBT assessment scores were missing. The
other 48 patients (48/79, 61%) with posttreatment data met
step-up criteria. In total, 11 patients stepped up to face-to-face
CBT (11/48, 23%). Reasons for not stepping up are given in
the flowchart (Figure 1). In the benchmark study, 172 patients
(172/242, 71.1%) met step-up criteria after I-CBT. Of them, 85
(49.4%) stepped up to face-to-face CBT [9].
Figure 1. Flowchart. CBT: cognitive behavioral therapy; CFS: chronic fatigue syndrome; f2f: face-to-face; I-CBT: internet-based cognitive behavioral
therapy; ICF: idiopathic chronic fatigue.
Patient Characteristics
Baseline characteristics are shown in Table 2. The proportion
of female patients was larger than that in the stepped care arms
of the RCT [9], with which the data were compared, which had
a relatively low proportion of females [8]. Age in years, fatigue
severity, and physical functioning did not significantly differ
between this study sample and the benchmark sample (see Table
2). Social functioning and impairment in daily functioning were
significantly worse in the MHC sample, whereas patients in the
benchmark sample reported significantly more additional CDC
symptoms.
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Table 2. Baseline characteristics of this study and the benchmark study.
Difference between samplesBenchmark sam-
ple—stepped care in
RCTb (n=242)
MHCa sam-
ple—stepped care in
routine clinical care
Baseline characteristic
P valueMann-Whitney
U test
t test (df)Chi-square (df)
.002—
—
d9.4 (1)c147 (60.7)78 (78)Proportion female, n (%)
.73—−0.345 (340)—36.9 (12.5)37.4 (11.9)Age (years; n=100), mean (SD)
.12—1.580 (340)—50.5 (4.9)49.6 (5.2)Fatigue severity (CISe; n=100), mean (SD)
.65—0.455 (338)—61.4 (19.7)60.3 (21.3)Physical functioning (SF-36f; n=98), mean
(SD)
.02—2.365 (336)—44.0 (23.7)37.2 (23.8)Social functioning (SF-36; n=96), mean
(SD)
.003—−2.957 (332)—23.2 (6.7)25.6 (6.5)Impairment daily functioning (WSASg;
n=92), mean (SD)
<.0017703——7 (2)6 (3)Number of additional CDCh symptoms
(0-9; n=86), median (IQRi)
aMHC: mental health care center.
bRCT: randomized controlled trial.
cn=342.
dNot applicable.
eCIS: Checklist Individual Strength.
fSF-36: Short Form-36.
gWSAS: Work and Social Adjustment Scale.
hCDC: Centers for Disease Control and Prevention.
iIQR: interquartile range.
Treatment Effect
As shown in Table 3, patients significantly improved on all
outcomes. Compared with the benchmark, the decrease in
fatigue severity (CIS) is lower in the MHC sample, as the change
score falls outside the 95% CI of the change in the benchmark
study. For physical functioning and social functioning, the
change scores fall within the CI of the benchmark. For
limitations measured with the WSAS, the change score is above
the CI of the benchmark.
For the sensitivity analysis, the CIS fatigue severity
postassessment scores of all 13 patients with missing data were
replaced with the maximum score of 56. This reduced the fatigue
change score to 10.1, which was still a significant improvement
(t=7.2, P<.001), that falls outside this CI.
Proportion of Patients With Clinically Significant
Improvement in Fatigue Severity
Data were missing for 13 patients, and it was assumed that they
did not show a significant change in fatigue severity. Of the
100 patients, 37 (37/100, 37%) had a reliable and clinically
significant improvement in fatigue severity and were no longer
severely fatigued. In the stepped care conditions in the tertiary
center, no CIS data were missing and 110 (110/242, 45.5%)
had a clinically significant improvement in fatigue. The
difference between the 2 improvement rates was not significant;
χ21(N=342)=2.1 and P=.15.
Subgroup Analyses
When restricting the analyses to patients who met CDC criteria
for CFS (n=73), scores on all outcomes were significantly
improved (Table 3). The change scores on all outcomes were
larger than that in the total group. All scores fall within the CIs
of the tertiary treatment center, except for the change score in
limitations (WSAS), which falls outside the CI of the
benchmark. A post hoc analysis of variance comparing the CFS
group with the ICF group (n=14) and the group for which,
because of missing data, it was unknown whether the diagnosis
was CFS or ICF (n=13), showed a group effect. CFS patients
had a significantly larger reduction in fatigue severity than the
patients with diagnosis unknown. Differences between the ICF
group and both other groups were not significant.
The proportion of patients with a reliable and clinically
significant improvement in fatigue severity was 29 out of 73
(40%). Data of 11 patients were missing, and no improvement
was assumed for them.
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Table 3. Treatment effect.
Effect size (d)P valuet testChange score (95% CI)Treatmentn (%)Outcome measure and selected group
PostPre
Fatigue severity (CISa)
1.14 (0.84-1.44)<.0018.512.6 (9.7 to 15.5)37.049.6100 (13)MHC—total groupb
1.31 (0.95-1.67)<.0018.314.4 (11.0 to 17.8)35.950.273 (15)MHC—CFS onlyc
1.47 (1.27-1.67)<.00117.814.9 (13.2 to 16.5)35.650.5242 (0)Benchmarkd
Physical functioning (SF-36e)
0.62 (0.34-0.91)<.001−5.6−13.4 (−18.1 to −8.7)73.560.1100 (32)MHC—total group
0.76 (0.42-1.10)<.001−5.9−16.4 (−21.9 to −10.9)75.459.073 (33)MHC—CFS only
0.71 (0.53-0.90)<.001−12.3−15.2 (−17.6 to −12.8)76.661.4242 (5)Benchmark
Social functioning (SF-36)
0.73 (0.44-1.01)<.001−5.4−20.4 (−27.9 to −12.9)57.537.0100 (34)MHC—total group
0.96 (0.61-1.30)<.001−6.0−25.6 (−34.0 to −17.2)59.333.773 (34)MHC—CFS only
0.84 (0.65-1.02)<.001−11.4−21.5 (−25.2 to −17.8)65.544.0242 (5)Benchmark
Limitations (WSASf)
1.08 (0.78-1.38)<.0018.310.3 (7.8 to 12.7)15.826.1100 (40)MHC—total group
1.24 (0.88-1.59)<.0017.911.4 (8.6 to 14.3)15.026.573 (40)MHC—CFS only
0.99 (0.81-1.18)<.00114.08.6 (7.4 to 9.8)14.623.2242 (14)Benchmark
aCIS: Checklist Individual Strength.
bMHC (mental health care center)—total group: all 100 participants, regardless of meeting Centers for Disease Control and Prevention criteria for
chronic fatigue syndrome.
cCFS (chronic fatigue syndrome) only: subgroup of 73 participants that met Centers for Disease Control and Prevention criteria for chronic fatigue
syndrome.
dBenchmark: patients who were allocated to the stepped care arms of the randomized control trial, all meeting Centers for Disease Control and Prevention
criteria for chronic fatigue syndrome.
eSF-36: Short Form-36.
fWSAS: Work and Social Adjustment Scale.
Of the 80 patients who intended to start I-CBT, 64 had
completed the post–I-CBT assessment, and 16 CIS fatigue
severity scores were imputed. The mean CIS fatigue score after
I-CBT was 36.7, which was on average 13.2 points lower than
that at the preassessment (95% CI 9.8-16.5; t=7.8; P<.001).
This change score falls within the 95% CI of the benchmark
from the patients who followed I-CBT in tertiary treatment
center (95% CI 11.1-14.2). A sensitivity analysis was performed
by replacing all missing CIS fatigue scores post–I-CBT with
the maximum fatigue score (56). This resulted in a change score
of 8.7 (95% CI 5.6-11.7; t=5.6; P<.001), which fell below the
benchmark.
Therapists’Attitude and Treatment Outcome of
Fatigue Severity
In total, 25 therapists participated in the study. Of them, 15
therapists treated at least one patient and completed attitude
questionnaires, 5 treated at least one patient but did not complete
these questionnaires, and 5 completed the questionnaires but
did not treat a patient. The number of patients per therapist
varied from 1 to 18.
The 20 therapists who treated patients were ranked based on
the median fatigue severity change score of their patients. The
10 therapists with the lowest median change score treated 43
patients, with a mean change score in fatigue severity of 9.0
points. The 10 therapists with the highest median change scores
treated 57 patients who had a mean change score of 15.7. The
difference between these means was significant (see Table 4).
No differences between the 2 groups were found in therapists’
attitudes, except for the Computer Competence scale. The
therapists with higher median fatigue change scores had
significantly higher scores on Computer Competence.
Furthermore, differences on baseline characteristics (fatigue,
physical functioning, social functioning, number of additional
CDC symptoms, level of limitations, age, and sex) of the patients
treated by both therapist groups were compared using t tests
and chi-square tests, and no difference was significant
(P=.07-.93).
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Table 4. Therapists attitude and treatment outcome (data of all 20 therapists who completed the questionnaires provided and of whom, 5 had not treated
a chronic fatigue syndrome patient during the study).
Statistical difference between thera-
pists with high and low median
TherapistsAll therapistsVariable
P valuetWith low medianWith high median
—
—
b43 (39)57 (48)100 (87)Patients treateda, n (%)
.022.429.015.712.7Change score in fatigue severity, mean
Attitude eHealthc, mean (SD)
.06−2.0525.8 (2.5)28.6 (2.5)28.0 (2.6)Possibilities of eHealth scale (range 9-45)
.710.3826.8 (4.6)25.6 (6.3)25.2 (5.9)eHealth Negative Effect Scale (range 7-35)
.04−2.287.0 (1.4)8.7 (1.3)8.1 (1.7)Computer Competence Scale (range 2-10)
Attitude manualized treatment, mean (SD)
>.990.0024.8 (4.1)24.8 (4.7)24.9 (4.1)Positive outcome (range 0-35)
.80−0.2513.8 (7.4)14.9 (8.1)14.6 (7.4)Negative process (range 0-50)
aNumber of patients with complete data.
bNot applicable.
ceHealth: electronic health.
The correlation between the fatigue severity change score per
therapist and the attitude subscales were as follows: .363 for
Possibilities of eHealth (P=.18), −.092 for eHealth Negative
Effect (P=.75), .271 for Computer Competence (P=.33), .119
for Positive Outcome of treatment manuals (P=.67), and −.186
with Negative Process of treatment manuals. None of the
correlations were significant (P=.51).
Discussion
Principal Findings
This is one of few studies that implemented and evaluated
eHealth in routine clinical care. It shows that I-CBT embedded
in stepped care for CFS can lead to a significant reduction in
fatigue severity and limitations in routine clinical care. The
outcomes were compared with those of the same treatment
format delivered in an RCT, in a tertiary treatment center for
CFS, the benchmark. Outcomes for limitations in functioning
were similar in both settings or even better in the implemented
care. Nevertheless, the decrease in fatigue severity was smaller
in the MHCs. Compared with the benchmark, relatively fewer
patients had a clinically significant improvement in fatigue
severity (reliable change in fatigue and no longer severely
fatigued) after stepped care, but the difference was not
statistically significant. It should be noted that the improvement
rate in the benchmark is also lower than what was previously
found in the tertiary treatment center in an face-to-face treatment
[3]. Although these studies are not entirely comparable, this
suggests that there is probably room for improvement in the
delivery of this treatment by MHCs in routine clinical care. We
will elaborate on this in the future directions section.
We found that I-CBT, the first step of stepped care, can be
delivered effectively in routine clinical care. It led to a
significant reduction of fatigue severity. Patients who received
I-CBT in the MHCs did not profit less from the intervention
than those in the tertiary treatment center. However, in the RCT,
there were no missing values, whereas in the MHCs, post–I-CBT
data of one-fifth of the patients had to be imputed. As treatment
outcome for research dropouts may not be the most favorable,
it is possible that we overestimated the efficacy of implemented
I-CBT. Our sensitivity analysis, in which we assumed that these
patients are maximally fatigued, showed a smaller reduction of
fatigue in the MHCs, falling below the benchmark.
An important finding is that one-fifth of the patients did not
start with I-CBT but directly commenced with face-to-face
CBT. In the benchmark study, almost all patients started with
I-CBT. Nevertheless, we can assume that patients who did not
want I-CBT did not participate in an RCT testing it, which is a
general limitation of testing I-CBT in an RCT. It is known that
15.5% of the patients eligible to enter the RCT refused because
they preferred face-to-face CBT. An important issue for the
interpretation of our results is that we cannot know how many
patients who started directly with face-to-face CBT would have
improved in I-CBT. They were probably not a random sample
of all eligible patients. If this subgroup, for example, already
expected to profit less from I-CBT, not including them might
have had led to inflated results of I-CBT. Likewise, if these
were mainly patients of therapists with little confidence in
I-CBT, who, therefore, less convincingly offered it, they might
have been better off in face-to-face CBT, which also would
have led to inflated results of I-CBT after implementation.
According to therapist reports, about 30% of patients who started
I-CBT dropped out during I-CBT. Although this figure is
informative, it should be noted that therapist reports may not
be the most reliable indication of dropout in I-CBT [9].
Furthermore, of the patients who were still severely fatigued
and impaired after implemented I-CBT, about 1 in 5 stepped
up to face-to-face CBT. In comparison, in the tertiary treatment
center, approximately half of the patients stepped up when still
fatigued or impaired after I-CBT. In the RCT, it was found that
stepping up generally led to additional therapy gains. This could
partly explain why in the RCT, patients had a larger decrease
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in fatigue severity: relatively more patients in the RCT received
both I-CBT and face-to-face CBT. The problem of not starting
and not stepping up is common in stepped care [37,38].
Another study [39] compared the outcome of stepped care for
CFS in routine clinical care (ie, MHC) with the outcome of
CBT in a tertiary treatment center. The first step was CBT using
a self-help booklet with therapist guidance via email, and the
second step was face-to-face CBT. Compared with outcomes
in the tertiary treatment center, the MHC showed a lower
reduction of fatigue severity and, contrary to our study, also a
lower increase in physical functioning. Interestingly, previous
studies found that the guided self-help, as well as the
face-to-face CBT, could be delivered as effectively in the MHC
as in the context of an RCT [5,6,26]. However, in combination
with face-to-face CBT, the results were less positive. This
suggests that there is something specific to stepped care that
makes it more difficult to deliver in routine clinical care than
face-to-face CBT, I-CBT, or guided self-help alone [39]. Several
explanations could be considered. Delivering face-to-face CBT
after a minimal intervention with limited results may demand
more treatment experience from therapists than starting
face-to-face CBT from the start, also because the patients in
need of face-to-face CBT may be relatively complex to treat
[6]. In our study, therapists were more experienced, and training
had paid special attention to these difficulties specific to stepped
care. Still, it seems that despite the training, many patients did
not step up after unsuccessful I-CBT.
In the comparison of routine clinical care and care in a tertiary
treatment center, it is important to consider possible differences
between patients of both settings that may influence outcome.
For CFS, it was found in routine clinical care that samples more
often comprised patients with psychiatric comorbidity [26],
which might negatively influence outcome [40]. Furthermore,
we anticipated the inclusion of patients with ICF, because MHCs
treat these as well, as they too benefit from CBT [22].
Interestingly, our study showed when only selecting patients
who met CDC criteria for CFS, the reduction of fatigue in the
MHCs did fall within the benchmark (whereas when selecting
the total group, this fell below the benchmark). Our post hoc
analysis showed that patients with ICF did not profit less than
patients with CFS, but the group of patients for whom the
diagnosis (ICF or CFS) was unknown had significantly lower
treatment outcome.
We evaluated the influence of therapist factors on treatment
outcome. In accordance with a former study investigating the
role of the therapist on treatment outcome after implementation
[17], we found considerable variance in outcome between
therapists. We expected that therapists’ attitudes toward eHealth
and manualized treatment would influence treatment outcome.
Unfortunately, because of the limited number of patients per
therapist, we were unable to perform the multilevel analysis we
planned, which is a limitation of the study. The correlations
between therapists’ attitudes and fatigue reduction were in the
expected direction, but none was significant. Replication with
more patients per therapist is needed, as it is likely that we
lacked statistical power because of the small sample size.
Strengths and Limitations
A limitation of the study is that the moments on which feedback
was given during the I-CBT were not exactly the same as in the
benchmark study. In the latter study, patients had received either
I-CBT with feedback on prescheduled moments (protocol-driven
therapist feedback) or I-CBT with feedback only when the
patient asked for it (on demand) [8,9]. As both treatment arms
did not differ in outcome, both were combined to calculate the
benchmark. In this study, therapists were advised to give
feedback according to the feedback schedule used in the
protocol-driven condition of the benchmark study, but during
supervision, it became clear that therapists did not always follow
the schedule.
Furthermore, step-up criteria differed slightly. Additional
face-to-face CBT was offered in both studies when patients
were still severely fatigued and impaired following I-CBT. In
the benchmark study, the Sickness Impact Profile 8 was used
to assess the level of disability, but it was too lengthy for use
in the MHCs. Therefore, the SF-36 was used to assess whether
severe limitations in physical or social functioning were present.
Although both instruments are used to assess limitations in
functioning, it is possible that a different subgroup of patients
were selected to step up using the 2 measures.
Another limitation is that we do not have information on usage
of the program, either for patients or for therapists. For example,
it is not recorded when therapist feedback was provided.
Furthermore, the duration of the face-to-face CBT and the
number of sessions was not registered.
Finally, the data collection was, to warrant patient privacy, done
by the therapists, and questionnaires were sometimes scored by
hand. This procedure may have reduced the reliability of data
collection.
There were some important strengths as well. First, our study
not only evaluated I-CBT in routine clinical care but also shed
light on how I-CBT can be embedded in routine care. Second,
by comparing the results with a benchmark, we were able to
put the results in perspective. Finally, we included multiple
treatment centers, across the Netherlands, which contributed to
ecological validity of our study.
Future Directions
The success of I-CBT and stepped care in routine clinical care
can probably be improved by aiming at avoiding dropout and
increasing the numbers of patients stepping up. To avoid
dropout, it would be important to know why patients dropped
out. Information on usage of the program would be helpful. If,
for example dropout occurs more during 1 treatment module
than another, that specific module could be improved. It is also
important to know how aspects of therapist guidance (quantity
and perceived quality) influenced dropout to improve the
therapist training.
Likewise, to encourage stepping up, it is important to know
what prevented patients from stepping up. The main reasons
given were that patients did not want CBT anymore or were
unable to start at that moment. More knowledge about reasons
for not wanting CBT is needed to develop strategies to increase
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the number of patients who step up. If, for example, the long
duration of treatment is a reason, one could evaluate the effect
of I-CBT sooner, for example, after 3 or 4 months, to step up
earlier. This would shorten the duration of the total treatment
and may help avoid the loss of motivation to step up [9].
Furthermore, other options to embed I-CBT in routine care
should be considered to increase the number of patients who
profit from treatment—by offering matched care, for example.
Unfortunately, it is not known which patients profit from I-CBT
and which patients would profit more from face-to-face CBT.
Future research should search for predictors of the outcome of
different treatment formats or determine if following patient
preference leads to better results. Therapists and patients may
be well capable of resolving together what treatment form would
work best for the patient. I-CBT and face-to-face CBT are both
based on the same treatment principles and protocol, and it is
mainly the form of communication that differs. It would be
interesting to compare CBT offered as stepped care with
preferred care, that is, either I-CBT or face-to-face CBT,
depending on the preference of the patient. It was found in a
meta-analysis that treatment outcome is higher when the patient
receives the treatment of preference [41].
Finally, it is important to also investigate long-term outcome
of implemented stepped care. This may be difficult to achieve
in an observational multicenter study but would be a valuable
contribution. A recent study showed that positive outcome for
CFS after CBT is only partially maintained at long-term
follow-up up to 10 years after treatment, as 37% still had fatigue
within normal ranges [3]. Although efforts should be made to
increase this proportion, it confirms the notion that one can
recover from CFS and maintain the gains. We cannot assume
that the long-term outcome for face-to-face CBT is the same as
I-CBT/stepped care. It may, for example, be possible that the
interventions at the end of the therapy (goal reaching, evaluation,
and preparing the future) are important to retain the
accomplishments, although probably a larger proportion of
patients did not reach these modules.
Conclusions
This is, to our knowledge, the first study to evaluate I-CBT for
CFS, embedded in stepped-care, in routine clinical care. I-CBT
was as effective as in tertiary care and could be embedded in
routine clinical care where additional face-to-face CBT was
offered if needed. Increasing the number of patients who step
up after I-CBT is the most important remaining issue for
implementation of stepped care.
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